BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on NVAX: Novavax NewsMORE Related ...

Their current contract was negotiated about five years ago. “The world has changed drastically. However, our management has ...

Novavax Inc. closed $15.40 short of its 52-week high ($23.86), which the company achieved on June 6th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...

SIOUX CITY, Iowa (KCAU) — Meet today’s Stray of the Day: Alfie. Alfie is a one-to-two-year-old male, short-hair, brown tabby ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual ... the news and media division of Thomson Reuters, is the ...

More doctors are looking out for the condition. But that’s not enough to explain the increase in the nation’s overall ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.